Spinal Elements released its Clutch interspinous process device.
Here are three things to know:
1. Clutch has been in use since receiving FDA 510(k) clearance in 2017. This expanded commercial release offers the device's proprietary spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening and migration.
2. The device's bone opposing surfaces are enhanced with Ti-Bond technology in order to provide immediate stability and long-term fixation.
3. The device is part of Spinal Elements' thoracolumbar portfolio.
More articles on MIS:
New case series highlights Wenzel Spine's VariLift-LX for endoscopic TLIF: 4 things to know
5 things to know about Mazor Robotics' Mazor X Surgical System